Inflammatory Bowel Diseases clinical trials
The registry lists 1,552 studies for Inflammatory Bowel Diseases across more than 10 countries. 423 are recruiting or about to start. 875 of them are mainly about Inflammatory Bowel Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 2 narrower conditions too, such as Crohn Disease: 3,921 studies, 934 open.
ClinicalTrials.gov finds 4,212 studies for Inflammatory Bowel Diseases. How that becomes 1,552 here
This page counts the studies the registry files under Inflammatory Bowel Diseases, and those it files under no condition that list Inflammatory Bowel Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 17, 2026. How condition pages count
- 4,212Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −2,275Filed under a narrower condition, counted on its own pageCrohn Disease 1,350 · Colitis, Ulcerative 922
- −17List Inflammatory Bowel Diseases as a condition, but the registry did not file them under itMost often written as “Pediatric Inflammatory Bowel Disease” (2), “Chronic Inflammatory Bowel Disease” (2), and “Chronic Inflammatory Bowel Diseases” (2). The registry filed 8 of them under no condition at all, and the others under other conditions only, most often Ataxia with vitamin E deficiency (2) and Lymphohistiocytosis, Hemophagocytic (2).
- −368Match it another way78 name it in the title, 2 in a keyword, and 288 by a synonym or other text the search reads.
- 1,552The count on this page
Get an email when these change. Save the Inflammatory Bowel Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Status
Who runs them
Assiut University (45) · Takeda (22) · Assistance Publique - Hôpitaux de Paris (14) · Massachusetts General Hospital (13) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (13) · Pfizer (12) · University of British Columbia (12) · Icahn School of Medicine at Mount Sinai (11)
What is being tested here
Drugs under test in Inflammatory Bowel Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Infliximab | 6 | 3 | 20 |
| Adalimumab | 3 | 3 | 9 |
| Mirikizumab | 3 | 4 | 6 |
| Vedolizumab | 2 | 2 | 7 |
| Vancomycin | 2 | 0 | 4 |
| GSK1070806 | 2 | 0 | 3 |
| Xylitol | 2 | 0 | 2 |
| Iron isomaltoside 1000 | 1 | 3 | 5 |
| Probiotic | 1 | 0 | 4 |
| Ustekinumab | 1 | 2 | 4 |
Drug classes tested here Corticosteroids 1 open · Antimetabolites 1 open · Statins 1 open · JAK inhibitors 16 · Tyrosine kinase inhibitors (TKIs) 16
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Feb 2027Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial) · Phase 3 · Radboud University Medical Center
- May 2027Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal · Phase 3 · Assistance Publique - Hôpitaux de Paris
- Jul 2027Use of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults · Phase 3 · Dr. Naveed Siddiqui
- Oct 2027A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease · Phase 3 · Janssen Research & Development, LLC
- Nov 2026Epidemiological Evaluation Of Chronic Kidney Disease In Pediatric Patients With Inflammatory Bowel Disease · Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
- Nov 2026Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT · Paul Szabolcs
- Nov 2026AIRE-2 Device for Study of Breath Analysis in IBD · McMaster University
- Dec 2026Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS) · University of Glasgow
- Dec 2026Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease · University Hospital, Akershus
- Dec 2026Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission · Asmaa mohammed abdelaal abdelaal
Who these studies take
Of the 275 Inflammatory Bowel Diseases studies recruiting now, 133 (48%) set no upper age limit and 115 (42%) stop at 75 or younger. 76 (28%) take children under 18. 8 (3%) are for women only and 2 (1%) for men only; 60 (22%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 57 (21%) | 55 (20%) |
| 18 | 254 (92%) | 248 (90%) |
| 30 | 238 (87%) | 231 (84%) |
| 40 | 236 (86%) | 231 (84%) |
| 50 | 233 (85%) | 228 (83%) |
| 65 | 216 (79%) | 212 (77%) |
| 75 | 190 (69%) | 185 (67%) |
| 85 | 147 (53%) | 142 (52%) |
Across all 1,552 studies, recruiting or not: 40% stop at 75 or younger and 27% at 65; 25% take children; 2% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Inflammatory Bowel Diseases studies take
Of 61 phase 2 interventional studies under Inflammatory Bowel Diseases, half reached primary completion within 27 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 12 mo4–30 · 51 studies | 9 mo3–13 · 35 studies | — |
| Phase 2 | 27 mo18–43 · 61 studies | — | 29 mo18–50 · 34 studies |
| Phase 3 | 44 mo33–83 · 28 studies | — | — |
| Phase 4 | 38 mo21–63 · 38 studies | — | 38 mo30–63 · 33 studies |
| Interventional, no phase | 26 mo14–50 · 297 studies | — | 27 mo14–50 · 283 studies |
| Observational | 36 mo20–122 · 281 studies | 34 mo24–44 · 37 studies | 38 mo20–132 · 244 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting3
- A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative ColitisNov 5, 2026NCT07747480
- A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative ColitisOct 28, 2026NCT07747467
- Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel DiseaseOct 28, 2026NCT07799428
Results posted1
Newly registered8
- Nut Supplementation in Inflammatory Bowel Disease: A Proof-of-Concept Study of Gut Microbiome and Metabolome EffectsNov 17, 2026NCT07941271
- A Study of HW201877 Capsules for Participants With Moderate to Severe Active Inflammatory Bowel Disease (IBD)Nov 17, 2026NCT07942766
- Phase 2 Study of pH Gastrilex™ (Enteric-Coated Amorphous Calcium Carbonate Capsules) in Moderate-to-Severe Crohn's DiseaseNov 10, 2026NCT07928700
- Effects of Different Physical Activity Strategies on Disease Activity of IBD PatientsNov 4, 2026NCT07916493
- Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO StudyNov 4, 2026NCT07916727
Show 3 moreShow fewer
- Safety, Tolerability and Pharmacokinetics of ICP-B161 in Healthy Adults VolunteersNov 3, 2026NCT07911982
- Study of Single and Multiple Ascending Doses of CM551 in Healthy ParticipantsOct 28, 2026NCT07900945
- Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel DiseaseOct 22, 2026NCT07888023
Studies
Recruiting first, then most recently updated. Showing 50 of 1,552. Browse all 1,552 → or search them.
- Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease ManagementEnrolling by invitationNCT06424769Not applicable1 country
- Online Pain Education for Crohn's Disease and Ulcerative ColitisEnrolling by invitationNCT07671313Not applicable1 country
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRecruitingNCT07012395Phase 236 countries
- A Study of HW201877 Capsules for Participants With Moderate to Severe Active Inflammatory Bowel Disease (IBD)Not yet recruitingNCT07942766Phase 21 country
- Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel DiseaseNot yet recruitingNCT06799039Early Phase 11 country
- Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel DiseaseNot yet recruitingNCT06510296Not applicable1 country
- Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn DiseaseRecruitingNCT045080881 country
- Inflammatory Bowel Disease Cohort in NantesRecruitingNCT062563931 country
- Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion Microbiota and Clinical Correlation (micSPIDER).Not yet recruitingNCT078126751 country
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07845487Phase 212 countries
- Study of XmAb412 in Healthy ParticipantsRecruitingNCT07713485Phase 11 country
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruitingNCT047513961 country
- PROactive and Early Infliximab Monitoring and oPTimization in Inflammatory Bowel DiseaseRecruitingNCT06758024Not applicable1 country
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 12 countries
- Longitudinal Immunophenotyping of Patients With Inflammatory Bowel DiseaseRecruitingNCT076195471 country
- Clinical and Basic Investigations Into Hermansky-Pudlak SyndromeRecruitingNCT000014561 country
- The Hugo RAS Colorectal CollaborativeNot yet recruitingNCT07541352
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDEnrolling by invitationNCT07652294Phase 224 countries
- Health and Exercise Response in Children With Chronic and Auto-immune PathologiesRecruitingNCT03913962Not applicable1 country
- Effects of Different Physical Activity Strategies on Disease Activity of IBD PatientsNot yet recruitingNCT07916493Not applicable
- MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel DiseaseEnrolling by invitationNCT06788340Phase 41 country
- Effect of Mediterranean Diet in Inflammatory Bowel DiseaseRecruitingNCT05973500Not applicable1 country
- A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative ColitisRecruitingNCT07747480Phase 11 country
- Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO StudyRecruitingNCT07916727Not applicable1 country
- A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved IndicationRecruitingNCT07612267Phase 47 countries
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruitingNCT06226883Phase 228 countries
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruitingNCT071023681 country
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT05923073Phase 317 countries
- A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)RecruitingNCT072422481 country
- A Study of Long Term Persistency of Guselkumab in Adult Participants With Inflammatory Bowel DiseaseRecruitingNCT078225291 country
- Safety, Tolerability and Pharmacokinetics of ICP-B161 in Healthy Adults VolunteersNot yet recruitingNCT07911982Phase 1
- Duloxetine in Inflammatory Bowel DiseasesRecruitingNCT07431606Phase 21 country
- ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human StoolRecruitingNCT068105181 country
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisRecruitingNCT06619990Phase 1/219 countries
- Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research ApproachRecruitingNCT046852001 country
- Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)RecruitingNCT07265570Phase 21 country
- Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel DiseaseRecruitingNCT07799428Not applicable1 country
- A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier HomeostasisRecruitingNCT05579392Not applicable1 country
- A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative ColitisRecruitingNCT07747467Phase 11 country
- Study of Single and Multiple Ascending Doses of CM551 in Healthy ParticipantsNot yet recruitingNCT07900945Phase 11 country
- Pathogenic Study of Adult Immune EnteropathiesRecruitingNCT042805101 country
- Robotic Inflammatory Bowel Disease Development, Learning and Efficacy StudyRecruitingNCT065794431 country
- Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruitingNCT000011841 country
- COVID-19 Booster and IIV Schedule in Immunocompromised HostsRecruitingNCT06599658Phase 21 country
- Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel DiseaseNot yet recruitingNCT07877649
- Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel DiseaseNot yet recruitingNCT07888023
- Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative ColitisRecruitingNCT05003947Phase 12 countries
- Biophysical Assessments of Acupuncture Points in Inflammatory Bowel DiseaseNot yet recruitingNCT07681895
- Cardiovascular Risk in Patients With IBDNot yet recruitingNCT07663201
- Intestinal Ultrasound Guided Management in Inflammatory Bowel DiseaseRecruitingNCT07775352Not applicable1 country